FTO has been suggested to play a tumorigenic role in acute myeloid leukemia (Li et al, 2017; Huang et al, 2019b), while inhibition of FTO exerts an extensive anti‐leukemic activity in vitro and in vivo (Su et al, 2018). The gene discussed is FTO; the disease is acute myeloid leukemia.